483
Patrick Odia, MDPatrick Odia, MD – FDA 483, Feb 16, 2024
Record Details
An FDA inspection of Patrick Odia, MD in Houston, TX, a clinical investigator site, revealed a significant issue regarding the conduct of an investigation. The primary finding was that the investigator failed to adequately supervise the study, specifically concerning the assessment of subject eligibility by a sub-investigator. This indicates a lack of adherence to the signed statement of investigator and the investigational plan.
View Company Profile
ID · 7438a6f8-f162-404c-b3f5-4d50fa6446f7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.